Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteinsWilliam W Lockwood, Kreshnik Zejnullahu, James E Bradner, et al.
Urologic Oncology|March 6, 2016
Approaches to minimize castration in the treatment of advanced prostate cancerKreshnik Zejnullahu, Maria G Arevalo, Charles J Ryan, et al.
JACC. Case Reports|May 22, 2026
Infective Endocarditis Mimicking Reactive Arthritis: A Diagnostic DetourHudson Lin, Claudia See, Neal Shah, et al.
Elife|June 6, 2015
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinomaArun M Unni, William W Lockwood, Kreshnik Zejnullahu, et al.
Open Forum Infectious Diseases|October 23, 2020
<i>Mycoplasma pneumoniae</i>-Induced Rash and Mucositis in a Previously Healthy Man: A Case Report and Brief Review of the LiteratureJocelyn S Gandelman, Elizabeth Y Kim, Anne M Grzegorczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancersKimio Yonesaka, Kreshnik Zejnullahu, Neal Lindeman, et al.
Cancer Research|November 23, 2012
Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathwayAlexis B Cortot, Claire E Repellin, Takeshi Shimamura, et al.
The Journal of Clinical Investigation|August 15, 2006
Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancerJeffrey A Engelman, Toru Mukohara, Kreshnik Zejnullahu, et al.
Science (New York, N.Y.)|April 28, 2007
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingJeffrey A Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, et al.
Clinical Genitourinary Cancer|June 29, 2017
High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate CancerTerence W Friedlander, Julie N Graff, Kreshnik Zejnullahu, et al.
Pageof 2